Conforma Therapeutics Raises $11M

San Diego-based Conforma Therapeutics announced yesterday that it has raised $11M in a final tranche of its Series C funding. Investors included Domain Associates, Forward Ventures, Inglewood Ventures, Lilly BioVentures, Novo A/S, Proquest Investments, RBC Capital Partners, RiverVest Venture Partners, and S.R. One Limited. All of the investors were part of the company's original Series C close. The company said that the funding will be used to advance the clinical development of the company's small molecule drugs. More information »